Trial · NCT02470091
Results by group75
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 75
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Disease Control Rate (Cohort I) | Cohort 1: Measurable | 1 | participants | ||
| Response Evaluation Criteria in Solid Tumors (RECIST) Response (Complete Response [CR] or Partial Response [PR] vs Not CR or PR) (Cohort I) | Cohort 1: Measurable | 0 | participants | ||
| Disease Control Rate (Cohort II) | Cohort 2: Resection | 10 | participants | ||
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 1: Measurable | Serum denosumab (ng/ml): Cycle 1, Day 1 | 0 | Standard Deviation 0 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 2: Resection | Serum denosumab (ng/ml): Cycle 1, Day 1 | 0 | Standard Deviation 0 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 1: Measurable | Serum denosumab (ng/ml): Cycle 1, Day 8 | 11.59 | Standard Deviation 3.836665219 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 2: Resection | Serum denosumab (ng/ml): Cycle 1, Day 8 | 10.81 | Standard Deviation 4.514421336 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 1: Measurable | Serum denosumab (ng/ml): Cycle 1, Day 15 | 20.57 | Standard Deviation 8.290958931 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 2: Resection | Serum denosumab (ng/ml): Cycle 1, Day 15 | 22.07 | Standard Deviation 10.0339424 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 1: Measurable | Serum denosumab (ng/ml): Cycle 1, Day 22 | 31.8 | Standard Deviation 12.85573802 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 2: Resection | Serum denosumab (ng/ml): Cycle 1, Day 22 | 31.56 | Standard Deviation 13.41044369 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 1: Measurable | Serum denosumab (ng/ml): Cycle 2, Day 1 | 30.57 | Standard Deviation 10.78239306 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 2: Resection | Serum denosumab (ng/ml): Cycle 2, Day 1 | 30.28 | Standard Deviation 11.77497346 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 1: Measurable | Serum denosumab (ng/ml): Cycle 3, Day 1 | 23.8 | Standard Deviation NA | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 2: Resection | Serum denosumab (ng/ml): Cycle 3, Day 1 | 27.49 | Standard Deviation 13.31277582 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 1: Measurable | Serum denosumab (ng/ml): Cycle 4, Day 1 | 23.7 | Standard Deviation NA | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 2: Resection | Serum denosumab (ng/ml): Cycle 4, Day 1 | 23.67 | Standard Deviation 11.83849653 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 1: Measurable | Serum denosumab (ng/ml): Cycle 6, Day 1 | 20.3 | Standard Deviation NA | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 2: Resection | Serum denosumab (ng/ml): Cycle 6, Day 1 | 31.22 | Standard Deviation 14.57292009 | ng/ml |
| Pharmacokinetic (PK) Parameters: Mean of Trough Concentrations of Denosumab | Cohort 1: Measurable | Serum denosumab (ng/ml): Cycle 6, Day 15 | 23.2 | Standard Deviation NA | ng/ml |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02470091/results